Download Programm_2015 fu r Homepage

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
9TH INTERNATIONAL EFR CONGRESS
VIENNA, AUSTRIA
APRIL 9TH – 11TH, 2015
PROGRAMME
BÉLA TELEKY, MD, FRCS
President of the EFR
IRENE KÜHRER, MD
Secretary General of the EFR
www.efrcancer.org
9 T H INTERNATIONAL EFR CONGRESS
OPENING ADDRESS
by the EFR President, Béla Teleky
It is a great pleasure and honour to invite you attending
the 9th EFR – European Federation for coloRectal Cancer
Congress to be held from April 9th – 11th, 2015 at the
Medical University of Vienna. Following the success of the previous
conferences, the main objectives of this meeting will be progress and future
developments in the treatment of colorectal cancer. The management of
colorectal cancer requires a multidisciplinary approach with individualized
treatment concepts due to stage and risk factors. The conference schedule
will provide you with the latest data of multimodality treatment of colorectal
cancer and the optimization of different treatment components.
The program of this Congress will focus on improved diagnostic options,
prognostic factors and surgical techniques, but also on the progress made in
the field of state-of-the-art-radio- and chemotherapy. The presentations have
been organized to allow sufficient time for interdisciplinary discussions.
Abstract submitters will have the chance to present their works. The best
three abstracts will be selected and honoured by the Ingeborg Hörhager
Prize.
The Austrian Capital, Vienna, also described as Europe s cultural capital, is a
metropolis with unique charm, vibrancy and flair. As a Clean and a safe city,
it boasts outstanding infrastructure and has all the inspiration that you could
wish for in order to discover this wonderful part of Europe, especially during
the spring time.
In the historical Belvedere, you will be given the chance of being intimately
close to famous paintings. Enjoying the evening at the Townhall Vienna you
will have the opportunity of getting to know new people, build new friendships and meet old acquaintances again.
We look forward to welcoming you to an inspiring congress in Vienna in 2015.
Béla Teleky, MD, FRCS
President of the EFR
2
KEY TOPICS
• Response to incomplete/complete remission after radiotherapy in
rectal cancer
• Optimal treatment sequence in the time of biomarkers
• New approaches in metastatic surgery of liver/lung
• Special considerations of management of CRC in elderly patients
• Challenges in the management of younger patients
• Controversies in the surgical management of metastatic disease
• Functional Imaging: Has the future already started?
• New treatment options: Endoluminal surgery
• Evidence-based treatment of inherited colon cancer
• Personalization or therapy: is there a patient based medicine?
• Strategies for abdominal recurrent disease
3
Key topics
• Laparoscopic workshop
9 T H INTERNATIONAL EFR CONGRESS
THURSDAY, APRIL 9TH
12:00 – 12:30 Biomarkers and Imaging 1
Opening Lecture: Wolfgang SCHÜTZ
Christoph ZIELINSKI
Michael GNANT
Thomas SZEKERES
Béla TELEKY: Welcome Words
Scientific Programme
12:30 – 14:00 Biomarkers and Imaging 1
14:00 – 14:30
Chair: Raimund JAKESZ
Michael TRAUNER
Gina BROWN (Austria): NN
Zoran KRIVOKAPIC (Serbia): Rectal cancer- surgeons
questions to the radiologist
Ahmed BA-SSALAMAH (Austria): Staging and re-staging
of colorectal cancer: Radiologic imaging modalities
Daniela KANDIOLER (Austria): Tailoring colon cancer
treatment: Prediction of effect of adjuvant 5-Fluorouracil
Alexander ENGEL (Australia): How to implement a
translational research program in rectal cancer
Discussion
coffee break
14:30 – 16:00 Biomarkers and Imaging 2
Chair: Fritz WRBA
NN
John MARSHAL (USA): Molecular profiling and its role in
curing GI cancers
Brigitte MARIAN (Austria): Fibroblast growth factor signaling in colorectal cancer
Michael BERGMANN (Austria): Oncolytic viruses in solid
cancer - clinical trials and praeclinical models
Iris NAGTEGAAL (Netherlands): (Molecular) Pathology of
liver metastases
Phil QUIRKE (United Kingdom): pT1 cancers or Pathology
in the UK bowel cancer screening. Whats important in the
molecular biology of CRC (??? Specify)
Discussion
4
Chair: László DAMJANOVICH
Friedrich HERBST
Adam DZIKI (Poland): Can we predict complete pathologic
response after neoadjuvant therapy in rectal cancer?
Vincenzo VALENTINI (Italy): Is adjuvant chemotherapy
necessary after preoperative radio(chemo)therapy?
Giovanni ROMANO (Italy): The pull-through procedure:
How to "refresh" an old operation
Francis SEOW-CHOEN (Singapore): The best method of
rectal resection for low rectal cancer-choice and indications
Ruth EXNER (Austria): Methylation markers in rectal
cancer
Marty WEISER (USA): Individualizing rectal cancer
treatment
Rainer SCHMID: Rectal Cancer - When not to operate?
5
Scientific Programme
16:30 – 18:00 Rectal Cancer 1: Individualizing Treatment Strategies
9 T H INTERNATIONAL EFR CONGRESS
FRIDAY, APRIL 10TH
Scientific Programme
08:30 – 10:00 Challenges in the Managent of Colon Cancer
10:00 – 10:20
Chair: Carlo STAUDACHER
NN
Nina SCHMIDT (Germany): Treatment patterns of mCRC
patients in Germany, France, Spain and Italy
Judith KARNER-HANUSCH (Austria): Lynch syndrome:
Genetics and clinical management
Jirˇí HOCH (Czech Republic): Colorectal cancer in elderly
patients - Czech experience (view) in data
Brendan MORAN (United Kingdom): Complete mesocolic
excision for colon cancer
Barbara TRIBL (Austria): Self-expandable metal stents for
obstructing colon cancer
Phil QUIRKE (United Kingdom): Mesocolic excisionr
coffee break
10:20 – 12:00 Rectal Cancer 2: Organ Sparing Options
Chair: György LÁZÁR
Anton STIFT
Bill HEALD (United Kingdom): "Complete response
thinking” – the impact on current management of rectal
cancer
Giovanni ROMANO (Italy): Local excision for rectal
cancer:how far can we go
Vincenzo VALENTINI (Italy): Organ sparing in rectal
cancer: myth or treatment option?
Brendan MORAN (United Kingdom): Recent advances in
surgical management of rectal cancer
Elena ORSENIGO (Italy): Risk factors for colorectal
anatomoses leakage
Ronan O'CONNELL (Ireland): NN
12:00 – 13:00 Lunch Symposium: SILS
Walter BRUNNER: NN
Gerd SILBERHUMER: NN
6
Chair: Ioannis G. KARAITIANOS
Norihiro KOKUDO (Japan): Role of adjuvant or neoadjuvant chemotherapy for surgical treatment of colorectal
liver metastases
Hans Jörg MISCHINGER (Austria): Surgical strategies for
synchronous colorectal liver metastases
Iris NAGTEGAAL (Netherlands): Metastatic patterns in
CRC
Irinel POPESCU (Romania): Synchronous metastases for
color-rectal carcinoma: Therapeutical strategy
Werner SCHEITHAUER (Austria): Metastatic colorectal
cancer – recent advances in in terms of an individualized
treatment strategy
Karin DIECKMANN (Austria): Stereotactic Radiosurgery,
one treatment option for patients with lung and liver
metastasis
14:30 – 16:00 Controversies in the Surgcial Management of Metastatic
Disease 2
16:00 – 16:30
Chair: NN
NN
Ronan O'CONNELL (Ireland): Trials that have changed my
practice
Tomáš SKRˇICˇKA (Czech Republic): Multimodal treastment
of colorectal hepatic metastases
Yuman FONG (USA): Robotic surgery for metastatic
colorectal cancer including use in simultaneous resection of
primary and metastases
Norihiro KOKUDO (Japan): Aggressive repeated liver
resection for metastatic colorectal cancer in the era of
advanced chemotherapy
Giovanni ROMANO (Italy): Predicting response after
neoadjuvant treatment for rectal cancer
Discussion
coffee break
7
Scientific Programme
13:00 – 14:30 Controversies in the Surgcial Management of Metastatic
Disease 1
9 T H INTERNATIONAL EFR CONGRESS
16:30 – 17:30 Consultant Corner
Chair: NN
NN
Alexander ENGEL
Carlo STAUDACHER
Lászlo DAMJANOVICH
Gyory LACAR
Anton STIFT
Scientific Programme
17:30 – 18:30 HIPEC Surgery
Chair: NN
NN
Thomas BACHLEITNER-HOFMAN (Austria): Experiences
with CRS and HIPEC at the Medical University of Vienna
(Austria)
Paolo DELRIO (Italy): Aggressive surgical approach and
proactive HYPEC for locally recurrent rectal cancer
HIPEC Surgery
Brendan MORAN (United Kingdom): CRS and HIPEC for
colorectal peritoneal metatases
8
SATURDAY, APRIL 11TH
10:30 – 11:00
Chair: Igor PRAVOSUDOV
NN
Vincenzo VALENTINI (Italy): What is the role of
preoperative radiochemotherapy in cT3N0 rectal cancer?
Mirko OMEJC (Slovenija): Neoadjuvant treatment with
capecitabine, radiotherapy and bevacizumab in locally
advanced rectal cancer – early and long term results
Elena ORSENIGO (Italy): Functional results after
multidisciplinary approach to rectal cancer:an evidence
based analysis
Irinel POPESCU (Romania): Robotic approach in rectal
cancer: What are the advantages?
Francis SEOW-CHOEN (Singapore): Robotic versus
laparoscopic rectal surgery-making it better
Marty WEISER (USA): Robotic rectal cancer surgery
Stefan RISS (Austria): Surgical treatment of rectal cancer in
the elderly
Marek SZCZEPKOWSKI (Poland): Parastomal Hernia
Repair – which operation is the best? State of art and
Bielanski Hospital experience
coffee break
11:30 – 12:30 Rectal Cancer 4: Endoluminal Surgery
12:30 – 13:30
Chair: Gabriela Berlakovich
NN
Paolo DELRIO (Italy): Transanal minimally invasive surgery
for local excision of rectal cancer
Jozef KORCEK (Slovakia): LAR with TEM without
protective ileostomy- 25 years experiences
Zaman MAMEDLI (Russia): From laparoscopic to trans-anal
mesorectal excision – comparision of approaches
Zilvinas SALADZINSKAS (Lituania): Transanal endoscopic
operations for early stage rectal cancer
Francis SEOW-CHOEN (Singapore): Management of large
colonic polyps
Hoerhager prize and Best Abtracts
13:30 – 14:00 Closing Remarks
9
Scientific Programme
08:30 – 10:30 Rectal Cancer 3: New Treatment Options
9 T H INTERNATIONAL EFR CONGRESS
C O N G R E S S O R G A N I S AT I O N
Scientific Secretariat
Irene Kührer, MD
Secretary General of the EFR
Vienna/Austria
e-mail: [email protected]
www.efrcancer.org
General Information
Registration
Kuoni Destination Management Austria
c/o EFR 2015
Lerchenfelder Gürtel 43/4/1
A-1160 Vienna/Austria
Phone: +43/1/319 76 90-57, Fax: +43/1/319 11 80
e-mail: [email protected]
Exhibition & Advertising
MAW Exhibitions & Advertising
Freyung 6
A-1010 Vienna/Austria
Phone: +43/1/536 63-48 or -82, Fax: +43/1/535 60 16
e-mail: [email protected]
Abstracts
The European Federation for ColoRectal Cancer is accepting abstract
submissions for poster presentations. The EFR will donate a poster prize for
the best submitted abstract. Abstracts must be submitted online via
www.efrcancer.org. Abstract Guidelines are availabe on the EFR website.
Deadline for Abstract Submission: March 6th, 2015
H O T E L A C C O M M O D AT I O N
A number of hotels offering a special congress rate have been selected.
For more information on the different hotels, please visit the congress
website at www.efrcancer.org.
Reservations can be made online when registering for the congress.
In case of questions please contact us either by phone at +43 1 319 76 90-57
or send your request to [email protected]
10
CONGRESS VENUE
Vienna General Hospital (AKH)
Hörsaalzentrum
Währinger Gürtel 18-20
A-1090 Vienna/Austria
Onsite-Registration, lectures and the industry exhibition are at the “Hörsaalzentrum”. Please follow the sign posting from the main entrance of the
General Hospital.
By car: The basement garage of the Vienna General Hospital provides
800 car parking spaces available for visitors. Entrance: Währinger Gürtel
By taxi: Taxis are located both in front of the main entrance and at the
entrance at Lazarettgasse.
By public transportation:
Underground: Direct access to the main entrance with the underground line
U6, station “Michelbeuern – AKH”
Tram: Line 5 and 33 (Station Lazarettgasse, entrance Spitalgasse)
ÖBB offers you a comfortable and stress-free option to your congress venue
and back again.
HÖRSÄLE AM SÜDGARTEN
11
General Information
How to get there:
9 T H INTERNATIONAL EFR CONGRESS
LANGUAGE
The official congress language is English.
No simultaneous translation is provided.
R E G I S T R AT I O N
ONLINE REGISTRATION ONLY!
To register for the 9th International EFR Congress, please use our online
registration system at www.efrcancer.org
General Information
Registration desk & EFR congress office
The EFR congress office as well as the registration desk at the Vienna
General Hospital will be open as follows:
Thursday, April 9th
th
11:00 – 17:30
Friday, April 10
07:45 – 17:30
Saturday, April 11th
07:45 – 12:30
Registration fees
Early Fee
until
06.03.2015
Regular Fee
after
08.04.2015
Onsite
Registration
EFR member
ö € 160.00
ö € 230.00
ö € 300.00
Non-member
ö € 280.00
ö € 350.00
ö € 425.00
AMIC/BÖC
ACO/ISDS members
ö € 245.00
ö € 310.00
ö € 370.00
Resident
ö € 95.00
ö € 95.00
ö € 95.00
*proof of eligibility must accompany registration
12
Delegate registration fees include:
• Access to all scientific sessions
• Access to poster exhibition
• Access to industry exhibition
• Free copy of all congress documentation
• Certificate of attendance
• Free copy of congress abstract book
Please prepare your presentation on a USB-stick with all your videos in the
same folder and hand it to the technician in the lecture hall at any time or in
the break. We use Powerpoint 10. On the speakers desk you’ll find a monitor,
a big push button to advance your animations or slides (only forward),
a mouse with all functions and a laser-pointer. Mac-user please bring your
own laptop for your presentation (the resolution must be 1024 x 768 and
60 cycles/sec). Please coordinate it with the technician in the break. Speakers
and chairs are asked to arrive 10 min before the start of their session/talk in
order to guarantee a smooth event and avoid delays.
IMPRINT
Publisher
European Federation for coloRectal Cancer (EFR)
Hohe Warte 56, 1190 Vienna, Austria
Phone: +43/1/378 0672
e-mail: [email protected]; URL: www.efrcancer.org
Content
No responsibility is taken for the correctness of this information. Information
as per date of printing.
Printing
ROBIDRUCK
Engerthstrasse 128, 1200 Vienna, Austria
e-mail: [email protected]; URL: www.robidruck.co.at
13
General Information
S P E A K E R I N F O R M AT I O N